BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 22377923)

  • 1. Acute and chronic skin graft-versus-host disease--pathophysiological aspects.
    Socié G; Peffault de Latour R; Bouziz JD; Rybojad M
    Curr Probl Dermatol; 2012; 43():91-100. PubMed ID: 22377923
    [TBL] [Abstract][Full Text] [Related]  

  • 2. GVHD pathophysiology: is acute different from chronic?
    Toubai T; Sun Y; Reddy P
    Best Pract Res Clin Haematol; 2008 Jun; 21(2):101-17. PubMed ID: 18503979
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Life-threatening graft-vs-host disease.
    Vargas-Díez E; García-Díez A; Marín A; Fernández-Herrera J
    Clin Dermatol; 2005; 23(3):285-300. PubMed ID: 15896544
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biological advances in acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.
    Duran-Struuck R; Reddy P
    Transplantation; 2008 Feb; 85(3):303-8. PubMed ID: 18301323
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
    Petersen SL
    Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pathophysiology of graft-versus-host disease.
    Ferrara JL; Reddy P
    Semin Hematol; 2006 Jan; 43(1):3-10. PubMed ID: 16412784
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The changing face of graft-versus-host disease.
    Schaffer JV
    Semin Cutan Med Surg; 2006 Dec; 25(4):190-200. PubMed ID: 17174839
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Histological evaluation of acute mucocutaneous graft-versus-host disease in nonmyeloablative hematologic stem cell transplants with an observation predicting an increased risk of progression to chronic graft-versus-host disease.
    Bridge AT; Nelson RP; Schwartz JE; Mirowski GW; Billings SD
    Am J Dermatopathol; 2007 Feb; 29(1):1-6. PubMed ID: 17284954
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interleukin-17-producing T-helper cells as new potential player mediating graft-versus-host disease in patients undergoing allogeneic stem-cell transplantation.
    Dander E; Balduzzi A; Zappa G; Lucchini G; Perseghin P; Andrè V; Todisco E; Rahal D; Migliavacca M; Longoni D; Solinas G; Villa A; Berti E; Mina PD; Parma M; Allavena P; Biagi E; Rovelli A; Biondi A; D'Amico G
    Transplantation; 2009 Dec; 88(11):1261-72. PubMed ID: 19996925
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prophylaxis and treatment of acute graft-versus-host disease.
    Chao NJ; Chen BJ
    Semin Hematol; 2006 Jan; 43(1):32-41. PubMed ID: 16412787
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute graft-versus-host disease: pathophysiology, clinical manifestations, and management.
    Couriel D; Caldera H; Champlin R; Komanduri K
    Cancer; 2004 Nov; 101(9):1936-46. PubMed ID: 15372473
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Total lymphoid irradiation for graft-versus-host disease protection.
    Kohrt H; Lowsky R
    Curr Opin Oncol; 2009 Jun; 21 Suppl 1():S23-6. PubMed ID: 19561409
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Graft-versus-host disease of the skin: life and death on the epidermal edge.
    Hofmeister CC; Quinn A; Cooke KR; Stiff P; Nickoloff B; Ferrara JL
    Biol Blood Marrow Transplant; 2004 Jun; 10(6):366-72. PubMed ID: 15148490
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute graft-versus-host disease: from the bench to the bedside.
    Socié G; Blazar BR
    Blood; 2009 Nov; 114(20):4327-36. PubMed ID: 19713461
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neurological manifestations of chronic graft-versus-host disease after allogeneic haematopoietic stem cell transplantation: report from the Consensus Conference on Clinical Practice in chronic graft-versus-host disease.
    Grauer O; Wolff D; Bertz H; Greinix H; Kühl JS; Lawitschka A; Lee SJ; Pavletic SZ; Holler E; Kleiter I
    Brain; 2010 Oct; 133(10):2852-65. PubMed ID: 20846944
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation between the kinetics of CD3+ chimerism and the incidence of graft-versus-host disease in patients undergoing allogeneic hematopoietic stem cell transplantation.
    Rupa-Matysek J; Lewandowski K; Nowak W; Sawiński K; Gil L; Komarnicki M
    Transplant Proc; 2011 Jun; 43(5):1915-23. PubMed ID: 21693300
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The cytokine modulation of acute graft-versus-host disease.
    Ferrara JL
    Bone Marrow Transplant; 1998 Jun; 21 Suppl 3():S13-5. PubMed ID: 9712485
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical update on graft-versus-host disease in children.
    Goddard DS; Horn BN; McCalmont TH; Cordoro KM
    Semin Cutan Med Surg; 2010 Jun; 29(2):92-105. PubMed ID: 20579598
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Advances in the understanding of acute graft-versus-host disease.
    Morris ES; Hill GR
    Br J Haematol; 2007 Apr; 137(1):3-19. PubMed ID: 17359368
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Host-reactive CD8+ memory stem cells in graft-versus-host disease.
    Zhang Y; Joe G; Hexner E; Zhu J; Emerson SG
    Nat Med; 2005 Dec; 11(12):1299-305. PubMed ID: 16288282
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.